Want Decades of Passive Income? 2 Stocks to Buy Right Now — Positive
AXP SPGI The Motley Fool — March 20, 2025Every so often, the market experiences some turmoil, and investors rush to safe stocks, like what's been happening during the past few weeks. If you've been at it long enough, you'll recognize that this is normal and won't sweat it.

Is the Vanguard S&P 500 ETF the Smartest Investment You Can Make Today? — Positive
VOO The Motley Fool — March 20, 2025It feels ironic to posit that an exchange-traded fund (ETF) Warren Buffett just sold out of could be the smartest investment you could make, but even the Oracle of Omaha himself might agree. He has said many times that most investors should invest in an ETF that tracks the S&P 500, and individual investors shouldn't make the mistake of comparing their personal portfolios to Berkshire Hathaway, which manages billions in its equity portfolio and has different investing goals.

RingCentral Benefits As AI Technologies Get Less Expensive — Positive
RNG Seeking Alpha — March 20, 2025RingCentral's positive GAAP operating earnings and pre-tax earnings in 4Q 2024 mark a significant milestone, driven by cost optimization and AI tool development. The company is expanding its AI-enabled product suite, enhancing features like call transcriptions, IVA, and CRM integration, benefiting from decreasing AI technology costs. Management expects ARR from new services to double by end-2025, with international expansion and strong UCaaS market position driving future growth.

Is Verizon's 6.2%-Yielding Dividend Still Safe After This Announcement? — Positive
VZ The Motley Fool — March 20, 2025Telecom giant Verizon Communications (VZ -0.72%) offers investors one of the highest-yielding payouts on the S&P 500, at around 6.2%. At that high a yield, you would need to invest around $16,100 to be able to collect $1,000 in annual dividend income.

Better Artificial Intelligence Stock: Strategy vs. Palantir — Neutral
MSTR PLTR The Motley Fool — March 20, 2025Strategy (MSTR 7.15%) and Palantir Technologies (PLTR 2.53%) are both investing in the growing artificial intelligence (AI) market. Strategy -- until recently known as MicroStrategy -- has for some time been considered more of a Bitcoin (BTC 3.05%) hoarder than a software company, but it has been rolling out more generative AI tools for its business intelligence (BI) platform.

Gold (XAU) Price Forecast: XAU Rally Extends, but Is a Reversal Coming? — Negative
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL FXEmpire — March 20, 2025Gold retreats after record highs as traders take profits. Fed signals rate cuts, inflation concerns persist, and geopolitical risks keep XAU/USD in focus.

Nutex Health to Present at the EDPMA Solutions Summit 2025 — Neutral
NUTX PRNewsWire — March 20, 2025HOUSTON , March 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced its CEO, Dr. Tom Vo, will present at the EDPMA Solutions Summit 2025. This event will take place from March 30 to April 2 at The Broadmoor in Colorado Springs, CO.

Broadcom (AVGO 3.50%) stock has delivered impressive returns to investors in the past five years. An investment of $1,000 made in mid-March 2020 would have grown into a holding worth more than $8,300 thanks to robust demand for the company's chips, which are deployed in a host of applications ranging from smartphones to data centers to cloud computing to broadband to storage, among others.

3 Emerging Tech Stocks That Could Supercharge Your Portfolio — Neutral
APLD JOBY POET The Motley Fool — March 20, 2025The first quarter of 2025 has brought significant challenges for technology investors. With the S&P 500 (^GSPC 1.08%) struggling amid renewed trade tensions and economic policy shifts under the Trump administration, many innovative companies have seen their market valuations compress dramatically -- regardless of their operational progress.

Health and safety remains top concern for directors and officers worldwide, according to Willis — Neutral
WTW GlobeNewsWire — March 20, 2025LONDON, March 20, 2025 (GLOBE NEWSWIRE) -- 80% of directors and officers consider health and safety risks to be very important or extremely important to their organisation, according to the latest Directors and Officers Liability Insurance Survey by Willis, a WTW business, (NASDAQ:WTW), in collaboration with Clyde & Co. Physical workplace risks were deemed the most important by 43% of respondents, followed by employee mental health and wellbeing consequences stemming from work (28%) and from personal matters (12%). For the first time since 2018 civil litigation and third party claims were included among the top seven concerns, with 63% of …

Intended Retirement of Independent Non-executive Directors and changes of composition of board committees — Neutral
HCM GlobeNewsWire — March 20, 2025HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM:HCM, HKEX:13) today announces that Mr Paul Rutherford Carter and Mr Graeme Allan Jack, who have both served as Independent Non-executive Directors of the Company for more than eight years, have informed the Company that they would not seek re-election after retiring from the Board at the forthcoming annual general meeting of the Company to be held on May 13, 2025 (“AGM”).

QYLD: A Fund That Carries More Risk In The Current Market Environment — Negative
QYLD Seeking Alpha — March 20, 2025The options strategy QYLD uses is not ideal for the kind of more volatile market conditions the indexes are currently seeing. Even though this fund should pay more income in the short term, the principle of this ETF. The managers of this Global X fund do not use discretion with their options strategy, so this ETF will likely have a harder time adapting to more fluid market conditions.

Eli Lilly (LLY 1.80%) has been around for almost 150 years, finding ways to innovate and grow. Today, it's the most valuable healthcare company in the world, with a market cap of $730 billion.

2025 has turned out to be the most exciting year for Alibaba's (BABA 0.37%) investors. The stock has surged 68% (as of this writing), reaching a level unseen since 2021.

Tesla is recalling 46,096 Cybertruck vehicles in the U.S. over an exterior panel that can detach while driving, the U.S. National Highway Traffic Safety Administration (NHTSA) said on Thursday.

3 Under-the-Radar Value AI Stocks With Market-Beating Potential — Positive
GEHC JCI NVT The Motley Fool — March 20, 2025These three stocks aren't conventionally seen as artificial intelligence (AI) stocks, yet AI is a critical part of the growth story of HVAC and building controls/software company Johnson Controls (JCI 1.58%), and electrical solutions company nVent Electric (NVT 2.45%). Meanwhile, integrating AI-enabled solutions is the key to long-term growth at GE HealthCare (GEHC 0.26%).

AMC stock price has remained in a tight range this year as investors focus on its recent financial earnings and the Box Office outlook for the year. It was trading at $3 on Thursday, a few points above the year-to-date low of $2.80.

Palantir Technologies Is 30% Below Its All-Time High: Here's How Far It Can Fall — Neutral
PLTR The Motley Fool — March 20, 2025For much of the last two-and-a-half years, the bulls have been in firm control on Wall Street. Since the 2022 bear market bottomed out, we've witnessed the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all gallop to numerous record-closing highs.

Neumora Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - NMRA — Neutral
NMRA PRNewsWire — March 20, 2025NEW YORK , March 20, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Neumora Therapeutics, Inc. (NASDAQ: NMRA). Shareholders who purchased shares of NMRA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
